Global pioneers of convenient treatment for allergy and immune related disorders.
Transforming lives by delivering convience.
As a Healthcare professional, you understand the importance of convenience in allergy treatments, because this allows you to deliver the best patient care.
We are a visionary immunology business with specialist experience in the research and development of allergy treatments.
Work with us.
A prospective, multicentre, open, non-interventional study to evaluate the risk-benefit assessment in the updosing phase of a house dust mite specific subcutaneous immunotherapy
Results of SCIT with a polymerised extract, associated with Microcrystalline Tyrosine, in allergic patients to Dermatophagoides spp. according to their sensitisation profile to Der p 1 and Der p 2
The health and economic impact of allergen therapy in patients with allergic rhinoconjunctivitis: real-word evidence from the Czech Republic
Strong dose-response on Immunoglobulin markers during a Phase II Allergen Immunotherapy study with subcutaneously administered Tyrosine adsorbed modified grass allergen + MPL
Relationship between Conjunctival Provocation Test and Immune Globulins in a positive Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen + MPL